ASX - By Stock
|
PVW |
Re:
Ann: Appendix 4G
|
|
aussilver
|
2 |
1.3K |
0 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
aussilver
|
74 |
23K |
7 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
74
|
23K
|
7
|
|
ASX - By Stock
|
EVE |
Re:
Ann: Appendix 4C - December Quarter 2021
|
|
aussilver
|
41 |
9.4K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
41
|
9.4K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Response to ASX Query
|
|
aussilver
|
15 |
5.0K |
5 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
15
|
5.0K
|
5
|
|
ASX - By Stock
|
PVW |
Re:
Ann: Proposed issue of securities - PVW
|
|
aussilver
|
8 |
2.5K |
1 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
8
|
2.5K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENT
|
|
aussilver
|
80 |
25K |
3 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
80
|
25K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
aussilver
|
16 |
5.3K |
5 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
16
|
5.3K
|
5
|
|
ASX - By Stock
|
DLI |
Re:
Ann: Capital Raising
|
|
aussilver
|
2 |
1.5K |
0 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
2
|
1.5K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Ethics Committee Approval Granted Phase III Clinical Trial
|
|
aussilver
|
39 |
12K |
8 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
39
|
12K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
MXC LSE Share Chat Forum
|
|
aussilver
|
27 |
15K |
2 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
27
|
15K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
MXC LSE Share Chat Forum
|
|
aussilver
|
27 |
15K |
4 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
27
|
15K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Where to from here
|
|
aussilver
|
384 |
160K |
1 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
384
|
160K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
knock knock
|
|
aussilver
|
1.0K |
706K |
2 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
1.0K
|
706K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma to receive grant for Malta production facility
|
|
aussilver
|
42 |
15K |
1 |
02/01/21 |
02/01/21 |
ASX - By Stock
|
42
|
15K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: ArtemiC Phase II Clinical Trial Results
|
|
aussilver
|
22 |
9.7K |
4 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
22
|
9.7K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: ArtemiC Phase II Clinical Trial Results
|
|
aussilver
|
22 |
9.7K |
6 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
22
|
9.7K
|
6
|
|
ASX - By Stock
|
PVW |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
aussilver
|
9 |
2.2K |
0 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
9
|
2.2K
|
0
|
|
ASX - By Stock
|
SYT |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
aussilver
|
11 |
3.0K |
1 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
11
|
3.0K
|
1
|
|
ASX - By Stock
|
DLI |
Re:
Ann: TNT ACQUIRES HISTORIC WESTERN AUSTRALIAN GOLD PROJECTS
|
|
aussilver
|
39 |
13K |
0 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
39
|
13K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
aussilver
|
72 |
20K |
1 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
72
|
20K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UPDATE ON ARTEMIC PHASE II TRIAL ON COVID-19 PATIENTS
|
|
aussilver
|
72 |
20K |
2 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
72
|
20K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: $15M FINANCE FACILITY TO FUND REVENUE GROWTH FOR KEY MARKETS
|
|
aussilver
|
101 |
33K |
2 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
101
|
33K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: $15M FINANCE FACILITY TO FUND REVENUE GROWTH FOR KEY MARKETS
|
|
aussilver
|
101 |
33K |
2 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
101
|
33K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Trading Halt
|
|
aussilver
|
45 |
16K |
1 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
45
|
16K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: BIOPHARMA APPOINTMENTS STRENGTHEN BOARD AND LEADERSHIP TEAM
|
|
aussilver
|
33 |
8.4K |
0 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
33
|
8.4K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: BIOPHARMA APPOINTMENTS STRENGTHEN BOARD AND LEADERSHIP TEAM
|
|
aussilver
|
33 |
8.4K |
1 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
33
|
8.4K
|
1
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
aussilver
|
102 |
35K |
1 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
102
|
35K
|
1
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
aussilver
|
102 |
35K |
2 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
102
|
35K
|
2
|
|
ASX - By Stock
|
RGT Biotech |
Re:
COVID-19 Trial - Supplementary material/Thoughts
|
|
aussilver
|
102 |
35K |
2 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
102
|
35K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: JV TO BE ESTABLISHED FOR REGISTRATION OF ARTEMIC IN RUSSIA
|
|
aussilver
|
60 |
16K |
2 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
60
|
16K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UK DISTRIBUTION AGREEMENT SIGNED FOR MGC PHARMA MEDICINES
|
|
aussilver
|
107 |
39K |
3 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
107
|
39K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: UK DISTRIBUTION AGREEMENT SIGNED FOR MGC PHARMA MEDICINES
|
|
aussilver
|
107 |
39K |
8 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
107
|
39K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
Ann: June Quarterly Activity and Cashflow Report
|
|
aussilver
|
52 |
15K |
3 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
52
|
15K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Suspension from Official Quotation
|
|
aussilver
|
70 |
26K |
4 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
70
|
26K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma to acquire 100% of Medicinal Cannabis Clinic
|
|
aussilver
|
44 |
16K |
2 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
44
|
16K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Proposed issue of Securities - MXC
|
|
aussilver
|
6 |
2.5K |
3 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
6
|
2.5K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Signs $60,000,000 Cannabinoids Offtake Agreement
|
|
aussilver
|
74 |
22K |
3 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
74
|
22K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Appendix 2A
|
|
aussilver
|
3 |
1.5K |
1 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
3
|
1.5K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma awarded Import Licence by Office of Drug Control
|
|
aussilver
|
37 |
14K |
0 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
37
|
14K
|
0
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma awarded Import Licence by Office of Drug Control
|
|
aussilver
|
37 |
14K |
2 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
37
|
14K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Letter from Cannaglobal to MGC Pharmaceuticals
|
|
aussilver
|
10 |
4.1K |
1 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
10
|
4.1K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Clinical Trial Site Expansion into India
|
|
aussilver
|
36 |
12K |
4 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
36
|
12K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: COVID-19 Clinical Trial Site Expansion into India
|
|
aussilver
|
36 |
12K |
2 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
36
|
12K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Legal Proceedings Commenced against Varm Cosmo
|
|
aussilver
|
120 |
55K |
2 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
120
|
55K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Pharma GM Webinar
|
|
aussilver
|
7 |
4.1K |
5 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
7
|
4.1K
|
5
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MXC Awarded 3-year EU GMP Manufacturing Licence
|
|
aussilver
|
4 |
2.5K |
2 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
4
|
2.5K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Sale of MGC Nutra to US CBD and Hemp Wellness Company
|
|
aussilver
|
86 |
33K |
2 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
86
|
33K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Sale of MGC Nutra to US CBD and Hemp Wellness Company
|
|
aussilver
|
86 |
33K |
2 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
86
|
33K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: 3,250 Prescriptions Milestone Surpassed
|
|
aussilver
|
50 |
18K |
3 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
50
|
18K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: 3,250 Prescriptions Milestone Surpassed
|
|
aussilver
|
50 |
18K |
2 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
50
|
18K
|
2
|
|